Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study
- PMID: 2010157
Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study
Abstract
To investigate the incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection, a prospective follow-up study was conducted in two consecutive groups of patients. Group I consisted of 984 patients (859 men and 125 women) with biopsy-proven chronic type B hepatitis, whereas group II consisted of 1,598 asymptomatic chronic carriers (998 men and 600 women) with normal serum aminotransferase activity. During a mean follow-up period of 4.0 +/- 2.3 yr, 19 patients (1.9%) of group I cleared HBsAg from their serum, whereas 35 patients (2.2%) in group II did so in a mean follow-up period of 2.7 +/- 1.4 yr. The annual incidence of delayed serum HBsAg clearance was 0.5% in group I and 0.8% in group II (p less than 0.02). The cumulative probability of HBsAg clearance was also higher in group II than in group I (p less than 0.007). Antibodies to HBsAg developed in 9 patients (47.4%) with chronic hepatitis and in 11 (31.4%) asymptomatic carriers who cleared serum HBsAg. Those who were HBeAg negative and those older than 40 at entry and those who exhibited cirrhosis during follow-up had a higher incidence of delayed HBsAg clearance. Gender, initial histological changes and hepatitis delta virus infection did not influence the occurrence of HBsAg clearance. Serum HBV DNA was not detectable by slot-blot hybridization but was still detectable by polymerase chain reaction in serum specimens collected within 1 yr of HBsAg clearance. Liver biopsy performed later in 10 patients showed no significant hepatitis activity or tissue HBV DNA, HBsAg or HBcAg.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Determination of hepatitis B virus DNA in serum using the polymerase chain reaction: clinical significance and correlation with serological and biochemical markers.Hepatology. 1991 Apr;13(4):632-6. Hepatology. 1991. PMID: 2010158
-
Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: clinical significance and correlation with serological markers.Turk J Gastroenterol. 2003 Sep;14(3):157-63. Turk J Gastroenterol. 2003. PMID: 14655057
-
Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis.Hepatology. 1995 Jul;22(1):25-9. Hepatology. 1995. PMID: 7601418
-
Hepatitis B surface antigen (HBsAg) in the liver of patients with hepatitis; a comparison with serological detection.J Clin Pathol. 1976 Feb;29(2):89-93. doi: 10.1136/jcp.29.2.89. J Clin Pathol. 1976. PMID: 777038 Free PMC article. Review.
-
Hepatology Clearance for Immunomodulation in Patients With Hepatitis B.Clin Liver Dis (Hoboken). 2019 Sep 2;14(2):78-85. doi: 10.1002/cld.757. eCollection 2019 Aug. Clin Liver Dis (Hoboken). 2019. PMID: 31508226 Free PMC article. Review. No abstract available.
Cited by
-
Future prospectives for the management of chronic hepatitis B.World J Gastroenterol. 2007 May 14;13(18):2554-67. doi: 10.3748/wjg.v13.i18.2554. World J Gastroenterol. 2007. PMID: 17552002 Free PMC article. Review.
-
Levels of hepatitis B virus (HBV) replication during the nonreplicative phase: HBV quantification by real-time PCR in Korea.Dig Dis Sci. 2007 Sep;52(9):2403-9. doi: 10.1007/s10620-006-9140-2. Epub 2007 Apr 11. Dig Dis Sci. 2007. PMID: 17429737
-
Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses.Lancet Gastroenterol Hepatol. 2019 Mar;4(3):227-238. doi: 10.1016/S2468-1253(18)30308-X. Epub 2019 Jan 22. Lancet Gastroenterol Hepatol. 2019. PMID: 30679109 Free PMC article.
-
Cohort profile: golestan hepatitis B cohort study- a prospective long term study in northern iran .Middle East J Dig Dis. 2014 Oct;6(4):186-94. Middle East J Dig Dis. 2014. PMID: 25349681 Free PMC article.
-
KASL clinical practice guidelines: management of chronic hepatitis B.Clin Mol Hepatol. 2016 Mar;22(1):18-75. doi: 10.3350/cmh.2016.22.1.18. Epub 2016 Mar 28. Clin Mol Hepatol. 2016. PMID: 27044762 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical